Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
- Resource Type
- article
- Source
- Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-2 (2023)
- Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 1756-9966